PREVEST DENPRO LTD

Prevest Denpro maintains a strong liquidity position, with a current ratio of 14.38, indicating a significant excess of current assets over current liabilities. The company holds INR 109.42 million in cash and equivalents, and has no long-term debt, supporting a debt-to-equity ratio of 0.0. This liquidity profile is well above the typical thresholds for the healthcare equipment industry, where working capital is often more constrained due to inventory and receivables cycles. The company's profitability is robust, with a return on equity (ROE) of 17.2% and a return on assets (ROA) of 16.13%. These figures are well above the industry median for ROE and ROA in the Advanced Medical Equipment & Technology sector, which typically ranges between 8-12% for ROE and 6-9% for ROA. The high ROE is driven by strong gross margins and efficient asset utilization, as evidenced by the INR 503.54 million gross profit on INR 630.28 million in revenue. Geographically and segment-wise, Prevest Denpro's revenue is concentrated in India, with no disclosed international operations in the latest financials. The company operates in two primary segments: clinical and laboratory products, and 3D resins. Clinical products include adhesives, composites, and impression materials, while laboratory products include acrylics and gypsum products. 3D resins are used in dental prostheses and surgical guides. The company's product portfolio is diversified across dental specialties, but the financial data does not provide a breakdown of revenue by segment. Looking ahead, the company is projected to maintain a stable growth trajectory, with no significant changes in revenue or operating income expected in the next fiscal year. The capital expenditure of INR 19.68 million is relatively modest, suggesting a focus on maintaining existing operations rather than aggressive expansion. The company's free cash flow of INR 168.90 million supports this conservative capital strategy and provides flexibility for future reinvestment or shareholder returns. Risk factors for Prevest Denpro are currently low, with no immediate liquidity or dilution flags detected. The company has no long-term debt and a low dilution risk, as shares outstanding remain unchanged between basic and diluted shares. The absence of dilution risk is reinforced by the lack of recent equity issuance or shelf registration activity. However, the company's reliance on the Indian market and the dental equipment sector exposes it to regulatory and economic risks, particularly in a sector where product innovation and compliance are critical. Recent events include the company's latest financial filing, which shows strong operating cash flow of INR 148.17 million and a net income of INR 181.55 million. No recent earnings call transcripts or major regulatory filings have been disclosed, suggesting a stable and predictable business environment. The company's financial performance is consistent with its historical trends, with no material changes in operating income or net income in the latest period.